Home / Companies / Leerink Partners Llc / Roles
Leerink Partners Llc H-1B role rows
Row-level LCA role declarations for Leerink Partners Llc, including title, SOC code, worksite, status, date fields, wage offer, prevailing wage, and source record evidence. Showing 31 returned rows using keyset pagination.
Summary
This view lists 31 H-1B LCA role records.
Offered wages among the returned rows range from $94,640 to $450,000.
Employers in the returned rows include Leerink Partners LLC.
LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
| Role | Employer | SOC | Status / visa | Decision | Worksite | Offered wage | Prevailing wage | Source |
|---|---|---|---|---|---|---|---|---|
| Senior Managing Director I-203-26029-600107 | Leerink Partners LLC | 11-3031.00 Financial Managers | Certified / E-3 Australian FY2026 | 2026-02-05 2026-03-31 to 2028-03-30 | Boston, MA, 02109 | $345,000 to $450,000 year | $251,285 | sr_dol_oflc_lca_2026_q2_row_077009 |
| Analyst II I-200-24354-557574 | Leerink Partners LLC | 13-2051.00 Financial and Investment Analysts | Certified - Withdrawn / H-1B FY2026 | 2025-12-15 2025-01-01 to 2027-12-31 | Boston, MA, 02109 | $125,000 year | $100,589 | sr_dol_oflc_lca_2026_q2_row_141354 |
| Associate I-200-25253-299420 | Leerink Partners LLC | 13-2051.00 Financial and Investment Analysts | Certified / H-1B FY2025 | 2025-09-17 2026-01-02 to 2029-01-01 | New York, NY, 10019 | $170,000 year | $148,678 | sr_dol_oflc_lca_2025_q4_row_018156 |
| Research Associate I-200-23221-252188 | Leerink Partners LLC | 13-2051.00 Financial and Investment Analysts | Certified - Withdrawn / H-1B FY2025 | 2025-08-29 2023-10-01 to 2026-09-30 | New York, NY, 10019 | $170,000 year | $112,715 | sr_dol_oflc_lca_2025_q4_row_040001 |
| Vice President I-200-25181-142586 | Leerink Partners LLC | 13-2099.01 Financial Quantitative Analysts | Certified / H-1B FY2025 | 2025-07-08 2025-12-03 to 2028-12-02 | New York, NY, 10019 | $190,000 year | $132,371 | sr_dol_oflc_lca_2025_q4_row_107176 |
| Analyst I I-200-25133-967488 | Leerink Partners LLC | 13-2051.00 Financial and Investment Analysts | Certified / H-1B FY2025 | 2025-05-19 2025-10-01 to 2028-09-30 | New York, NY, 10019 | $110,000 year | $85,301 | sr_dol_oflc_lca_2025_q3_row_119307 |
| Associate I-200-25128-952568 | Leerink Partners LLC | 13-2051.00 Financial and Investment Analysts | Certified / H-1B FY2025 | 2025-05-15 2025-10-01 to 2028-09-30 | Boston, MA, 02109 | $135,000 year | $100,589 | sr_dol_oflc_lca_2025_q3_row_125048 |
| Associate II I-200-25128-952699 | Leerink Partners LLC | 13-2051.00 Financial and Investment Analysts | Certified / H-1B FY2025 | 2025-05-15 2025-10-01 to 2028-09-30 | Boston, MA, 02109 | $200,000 year | $128,981 | sr_dol_oflc_lca_2025_q3_row_126238 |
| Analyst I I-200-25128-956033 | Leerink Partners LLC | 13-2051.00 Financial and Investment Analysts | Certified / H-1B FY2025 | 2025-05-15 2025-10-01 to 2028-09-30 | New York, NY, 10019 | $110,000 year | $85,301 | sr_dol_oflc_lca_2025_q3_row_127800 |
| Analyst II I-200-24354-557574 | Leerink Partners LLC | 13-2051.00 Financial and Investment Analysts | Certified / H-1B FY2025 | 2024-12-30 2025-01-01 to 2027-12-31 | Boston, MA, 02109 | $125,000 year | $100,589 | sr_dol_oflc_lca_2025_q1_row_004692 |
| Analyst II I-200-24296-424167 | Leerink Partners LLC | 13-2051.00 Financial and Investment Analysts | Certified / H-1B FY2025 | 2024-10-29 2024-11-05 to 2027-11-04 | New York, NY, 10019 | $125,000 year | $115,731 | sr_dol_oflc_lca_2025_q1_row_071857 |
| Analyst III I-200-24275-376341 | Leerink Partners LLC | 13-2051.00 Financial and Investment Analysts | Certified / H-1B FY2025 | 2024-10-08 2024-11-16 to 2027-11-15 | New York, NY, 10019 | $135,000 year | $115,731 | sr_dol_oflc_lca_2025_q1_row_097381 |
| Analyst I I-200-24103-882990 | Leerink Partners LLC | 13-2051.00 Financial and Investment Analysts | Certified / H-1B FY2024 | 2024-04-19 2024-10-01 to 2027-09-30 | Charlotte, NC, 28203 | $110,000 year | $86,486 | sr_dol_oflc_lca_2024_q3_row_180594 |
| Analyst I I-200-24096-860010 | Leerink Partners LLC | 13-2051.00 Financial and Investment Analysts | Certified / H-1B FY2024 | 2024-04-12 2024-10-01 to 2027-09-30 | Boston, MA, 02109 | $110,000 year | $90,688 | sr_dol_oflc_lca_2024_q3_row_195704 |
| Vice President, Equity Research I-200-24088-837478 | Leerink Partners LLC | 13-2099.01 Financial Quantitative Analysts | Certified / H-1B FY2024 | 2024-04-04 2024-04-26 to 2027-04-25 | New York, NY, 10019 | $185,000 year | $115,086 | sr_dol_oflc_lca_2024_q3_row_210908 |
| Senior Managing Director I-203-24066-777176 | Leerink Partners LLC | 11-3031.00 Financial Managers | Certified / E-3 Australian FY2024 | 2024-03-13 2024-04-08 to 2026-04-07 | Boston, MA, 02109 | $450,000 year | $227,552 | sr_dol_oflc_lca_2024_q2_row_030195 |
| Director I-203-24026-669809 | Leerink Partners LLC | 11-3031.00 Financial Managers | Certified - Withdrawn / E-3 Australian FY2024 | 2024-03-06 2024-04-08 to 2026-04-07 | Boston, MA, 02109 | $275,000 year | $227,552 | sr_dol_oflc_lca_2024_q2_row_040924 |
| Associate, I, Equity Capital Markets I-203-24018-650108 | Leerink Partners LLC | 13-2051.00 Financial and Investment Analysts | Certified / E-3 Australian FY2024 | 2024-01-25 2024-02-15 to 2026-02-14 | New York, NY, 10019 | $175,000 year | $112,715 | sr_dol_oflc_lca_2024_q2_row_099651 |
| Associate III I-203-23355-584355 | Leerink Partners LLC | 13-2051.00 Financial and Investment Analysts | Certified / E-3 Australian FY2024 | 2023-12-29 2024-01-16 to 2026-01-15 | New York, NY, 10019 | $225,000 year | $143,125 | sr_dol_oflc_lca_2024_q1_row_000118 |
| Research Associate I-200-23286-429529 | Leerink Partners LLC | 13-2051.00 Financial and Investment Analysts | Certified - Withdrawn / H-1B FY2024 | 2023-12-06 2023-10-30 to 2026-10-29 | New York, NY, 10019 | $120,000 year | $112,715 | sr_dol_oflc_lca_2024_q1_row_024204 |
| Research Associate I-200-23307-477144 | Leerink Partners LLC | 13-2051.00 Financial and Investment Analysts | Certified / H-1B FY2024 | 2023-11-13 2024-01-02 to 2027-01-01 | New York, NY, 10019 | $150,000 year | $143,125 | sr_dol_oflc_lca_2024_q1_row_047174 |
| Analyst II I-200-23236-292670 | Leerink Partners LLC | 13-2051.00 Financial and Investment Analysts | Certified / H-1B FY2023 | 2023-08-31 2023-10-01 to 2026-09-30 | New York, NY, 10019 | $125,000 year | $112,715 | sr_dol_oflc_lca_2023_q4_row_049212 |
| Research Associate I-200-23221-252188 | Leerink Partners LLC | 13-2051.00 Financial and Investment Analysts | Certified / H-1B FY2023 | 2023-08-16 2023-10-01 to 2026-09-30 | New York, NY, 10019 | $170,000 year | $112,715 | sr_dol_oflc_lca_2023_q4_row_072306 |
| EQUITY RESEARCH ASSOCIATE - MEDICAL DEVICES I-200-18054-984272 | Leerink Partners LLC | 13-2051 | CERTIFIED-WITHDRAWN / H-1B FY2018 | 2018-06-26 | New York, NY, 10019 | $105,000 to $0 year | $101,254 | sr_dol_oflc_lca_2018_q2_row_492473 |
| EQUITY LARGE CAP BIOTECHNOLOGY RESEARCH ASSOCIATE I-200-17072-084474 | Leerink Partners LLC | 13-2051 | CERTIFIED-WITHDRAWN / H-1B FY2018 | 2018-06-12 | New York, NY, 10171 | $125,000 to $170,000 year | $124,592 | sr_dol_oflc_lca_2018_q2_row_435268 |
| INVESTMENT BANKING ASSOCIATE II I-203-17180-323676 | Leerink Partners LLC | 13-2051 | CERTIFIED / E-3 Australian FY2017 | 2017-07-07 | Boston, MA, 02110 | $150,000 to $0 year | $110,032 | sr_dol_oflc_lca_2017_q2_row_525909 |
| RESEARCH ASSOCIATE I-200-17061-103996 | Leerink Partners LLC | 13-2051 | CERTIFIED-WITHDRAWN / H-1B FY2017 | 2017-06-27 | New York, NY, 10171 | $105,000 to $0 year | $95,160 | sr_dol_oflc_lca_2017_q2_row_513895 |
| EQUITY LARGE CAP BIOTECHNOLOGY RESEARCH ASSOCIATE I-200-17072-084474 | Leerink Partners LLC | 13-2051 | CERTIFIED / H-1B FY2017 | 2017-03-21 | New York, NY, 10171 | $125,000 to $170,000 year | $124,592 | sr_dol_oflc_lca_2017_q2_row_326080 |
| EQUITY RESEARCH ASSOCIATE-SPECIALTY/GENERIC PHARMACEUTICALS I-200-16341-912426 | Leerink Partners LLC | 13-2051 | CERTIFIED / H-1B FY2017 | 2016-12-13 | Boston, MA, 02110 | $105,000 to $0 year | $85,862 | sr_dol_oflc_lca_2017_q2_row_072414 |
| ASSOCIATE, HEALTHCARE SERVICES I-200-16050-705516 | Leerink Partners LLC | 13-2051 | CERTIFIED-WITHDRAWN / H-1B FY2016 | 2016-07-29 | New York, NY, 10171 | $94,640 to $0 year | $94,640 | sr_dol_oflc_lca_2016_q2_row_069506 |
| EQUITY RESEARCH ASSOCIATE, BIOTECHNOLOGY I-200-16022-776101 | Leerink Partners LLC | 13-1161 | CERTIFIED-WITHDRAWN / H-1B FY2016 | 2016-07-29 | New York, NY, 10171 | $105,000 to $0 year | $92,976 | sr_dol_oflc_lca_2016_q2_row_045199 |
End of returned pageReset
Frequently asked questions
- What are the offered H-1B wages for Leerink Partners Llc H-1B role rows?
- Offered wages among the returned Leerink Partners Llc H-1B role rows rows range from $94,640 to $450,000 in DOL LCA filings. LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
Get this page with API
Rendered from the bluedoor H-1B Jobs API. Reproduce it:
GET https://api.bluedoor.sh/h1b-jobs/v1/roles?limit=50&company=leerink+partners+llcJSON